Biomet Posts Drop In Quarterly Profit

Biomet reported around 77% drop in its earnings for the quarter ended August 31. In April, Biomet agreed to be bought by Zimmer Holdings ZMH for around $13.35 billion in cash and stock. Biomet posted a quarterly profit of $7.3 million, versus a year-ago profit of $31.1 million. Excluding items, the company's adjusted net income climbed to $94.6 million versus $77.1 million. Its sales climbed 6% to $774.8 million. The company's sales in spine and bone healing division jumped 20.9%. Knee sales gained 4.3%, while hip sales jumped 3.8% in the period. Research and development costs increased 14%, while selling and administrative expenses climbed 15% in the quarter.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!